Gilead Sciences (GILD) PT Raised to $120 at Wells Fargo
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq set for sharp drop as Amazon, Intel amplify AI spending worries
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $165.61 --0%
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 43 | New: 7
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 43 | New: 7
Join SI Premium – FREE
Wells Fargo analyst Mohit Bansal raised the price target on Gilead Sciences (NASDAQ: GILD) to $120.00 (from $105.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Gilead Sciences (GILD) PT Raised to $195 at UBS
- PG&E Corporation (PCG) PT Raised to $15 at UBS
- Gilead Sciences (GILD) PT Raised to $200 at Scotiabank
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
